Toronto, Ontario--(Newsfile Corp. - January 2, 2026) - Bold Ventures Inc. (TSXV: BOL) (the "Company" or "Bold") is pleased to announce that further to its news release of December 16, 2025, it has closed its non-brokered private placement offering for gross proceeds of $776,800, through the placement of 6,000,000 working capital units (the "WC Units") of the Company at a price of $0.08 per WC unit for $480,000 (the "WC Offering") and 3,297,776 Flow Through units (the "FT Units") at a price of $0.09 per FT ...

Core Insights - The company reported solid business fundamentals despite a challenging funding environment, with key positive drivers of performance continuing into Q2 [1][2] - Total revenue for Q2 was $173 million, with a notable settlement payment of $68 million from patent litigation contributing to the financial results [4][21] - The company is focused on advancing technology leadership in single-cell and spatial biology, with new product launches expected to enhance capabilities and drive growth [10][12] Financial Performance - Total revenue for Q2 was $172.9 million, representing a 13% increase year-over-year, while excluding the settlement revenue, it was $145.6 million, down 5% [21] - Consumables revenue was $122.2 million, down 1%, with spatial consumables revenue increasing by 24% to $36.4 million, driven by Xenium products [21] - Operating income for Q2 was $30.1 million compared to an operating loss of $41.7 million in the previous year, indicating a significant turnaround [24][25] Market Dynamics - The funding environment remains uncertain, particularly in the academic sector, leading to cautious customer spending and extended project timelines [2][7] - Despite these challenges, there is a strong demand for single-cell and spatial biology tools, with researchers increasingly investing in these technologies [8][9] - The company noted a temporary increase in purchasing activity in China, driven by customers accelerating orders ahead of potential tariff changes, estimating a $4 million revenue impact from this pull forward [23][51] Product Development and Innovation - The company launched several new products, including Visium HD 3 Prime and Flex v2, aimed at increasing throughput and lowering costs for researchers [10][11] - The acquisition of Scale Biosciences is expected to enhance the company's capabilities in single-cell analysis, making it more powerful and accessible [16][17][18] - The company is prioritizing the integration of new technologies to support larger-scale applications and maintain high-quality data standards [17][18] Customer Engagement and Sentiment - The company is closely monitoring customer sentiment and remains aligned with them to navigate the uncertain funding landscape [2][7] - Conversations with customers indicate that clarity on future budgets and the actual disbursement of funds are critical for unlocking spending [8][64] - The company is optimistic about the long-term potential of its products, as customer feedback remains positive regarding the quality and utility of its offerings [6][48]

Core Viewpoint - Fancamp Exploration Ltd. has announced a normal course issuer bid (NCIB) to repurchase up to 12,118,116 common shares, representing approximately 5% of its outstanding shares, as a strategy to enhance long-term shareholder value and address perceived undervaluation of its stock [1][3][2]. Summary by Sections Normal Course Issuer Bid (NCIB) - The Board of Directors has authorized the NCIB, which is subject to approval from the TSX Venture Exchange (TSX-V) [1]. - The NCIB is expected to commence around December 16, 2025, and will last for 12 months unless completed or terminated earlier [4]. - The purchases will be made on the open market at prevailing market prices, with the actual number and timing of shares purchased dependent on market conditions [2][3]. Management Commentary - Rajesh Sharma, President and CEO, stated that the NCIB reflects the belief that the current share price does not accurately represent the Corporation's value and future prospects, especially during the Spin Out process [2]. Financial Strategy - The Corporation views the repurchase of its shares as a suitable use of financial resources aimed at increasing long-term shareholder value [3]. - The NCIB is part of a broader strategy to enhance shareholder returns amid ongoing developments in the Corporation's business [3]. Additional Updates - Fancamp has entered into an amendment to an option agreement with Harfang Exploration Inc. to acquire up to an 80% interest in the Egan mineral property, pending TSX-V approval [6]. - The amendment specifies that shares issued to Harfang will be priced based on the volume-weighted average trading price over the preceding 10 trading days, with a minimum price of $0.064 per share [6]. Company Overview - Fancamp is focused on mineral exploration with interests in various high-potential projects across Canada, including copper, gold, zinc, and titanium [7]. - The Corporation holds significant interests in several mining operations and is developing advanced technologies for titanium extraction and waste recycling [8].

Core Viewpoint - Fancamp Exploration Ltd. has authorized a normal course issuer bid (NCIB) to repurchase up to 12,118,116 common shares, representing approximately 5% of its outstanding shares, as a strategy to enhance long-term shareholder value and address perceived undervaluation of its stock [1][3][4] Group 1: Normal Course Issuer Bid (NCIB) - The NCIB is subject to approval from the TSX Venture Exchange and is expected to commence around December 16, 2025, lasting for 12 months or until completed [4] - The purchases will be made on the open market at prevailing market prices, with the actual number and timing of repurchases dependent on market conditions [2][3] - The Board believes that repurchasing shares is an appropriate use of financial resources to increase shareholder value [3] Group 2: Management Commentary - Rajesh Sharma, President and CEO, stated that the NCIB reflects the belief that the current share price does not accurately represent the company's future prospects, especially during the spin-out process [2] - The management team is focused on creating value through strategic interests in high-potential mineral projects and monetization opportunities [7][8] Group 3: Recent Developments - Fancamp has entered into an amendment to an option agreement with Harfang Exploration Inc. to acquire up to an 80% interest in the Egan mineral property, contingent on TSX-V approval [6] - The amendment specifies that shares issued to Harfang will be priced based on the volume-weighted average trading price over the preceding 10 trading days, with a minimum price of $0.064 per share [6]

Core Viewpoint - Inomin Mines Inc. experienced a significant share price increase of 20% during trading, indicating heightened investor interest and activity in the stock [1][2]. Group 1: Stock Performance - The share price rose to a high of C$0.10 before closing at C$0.09, up from a previous close of C$0.08 [1]. - Trading volume surged to approximately 902,372 shares, marking an 821% increase compared to the average daily volume of 98,010 shares [1]. - The stock's 50-day simple moving average is C$0.08, while the 200-day simple moving average is C$0.05 [2]. Group 2: Company Overview - Inomin Mines Inc. is an exploration stage company focused on the identification, acquisition, exploration, and evaluation of mineral properties in Canada and Mexico [3]. - The company explores for various mineral deposits, including magnesium, nickel, gold, silver, copper, chromium, cobalt, and zinc [3]. - Inomin Mines was incorporated in 2012 and is based in Vancouver, Canada [3]. Group 3: Financial Metrics - The company has a market capitalization of C$4.41 million [2]. - Inomin Mines has a price-to-earnings (PE) ratio of -9.00, indicating it is currently operating at a loss [2]. - The stock has a beta of 4.97, suggesting high volatility compared to the market [2].

Group 1 - Inomin Mines Inc.'s stock price increased by 20% during trading, reaching a high of C$0.10 and last trading at C$0.09 [1] - The trading volume surged to 902,372 shares, an increase of 821% compared to the average session volume of 98,010 shares, with the previous close at C$0.08 [1] Group 2 - Inomin Mines has a market capitalization of C$4.41 million, a P/E ratio of -9.00, and a beta of 4.97 [2] - The company's 50-day moving average price is C$0.08, while the 200-day moving average price is C$0.05 [2] Group 3 - Inomin Mines Inc. is an exploration stage company focused on identifying, acquiring, exploring, and evaluating mineral properties in Canada and Mexico, targeting deposits of magnesium, nickel, gold, silver, copper, chromium, cobalt, and zinc [3] - The company was incorporated in 2012 and is based in Vancouver, Canada [3]

Core Viewpoint - Fancamp Exploration Ltd. has announced a strategic reorganization through a Spin Out of its core exploration assets into a new company, Goldera Exploration Ltd., aimed at unlocking value and enhancing market recognition for shareholders [1][2][3] Summary by Sections Spin Out Details - The Spin Out will transfer all core exploration assets to Goldera, with shareholders receiving shares in Goldera proportional to their holdings in Fancamp, without altering their existing interests in Fancamp [1][4] - The Spin Out is designed to create two distinct growth platforms, allowing for focused capital attraction and new investor interest [2][3] Corporate Structure Post-Spin Out - Post-Spin Out, Fancamp will retain all marketable securities, financial instruments, and royalties, consolidating them into a cash-flow-oriented entity focused on growth and strategic acquisitions [8][10] - Goldera will focus solely on exploration, holding significant projects such as the Egan Gold Project and the Acadian Gold Joint Venture, which are located in high-potential mineral regions [6][9] Financial Aspects - Goldera is expected to be fully funded through a concurrent non-brokered private placement to support work programs and general working capital [3] - Fancamp's existing portfolio includes over $20 million in marketable securities and a $34.5 million secured convertible note, generating significant annual income [10] Regulatory and Approval Process - The Spin Out requires approval from the Supreme Court of British Columbia and a two-thirds majority vote from Fancamp shareholders at a forthcoming meeting [4][11] - Fancamp plans to apply for a listing of Goldera on the TSX Venture Exchange and to update its own listing status from a Mining Issuer to an Investment Issuer [4][11] Future Outlook - The completion of the Spin Out and related transactions is anticipated around Spring 2026, subject to customary conditions and approvals [11][12] - The reorganization aims to ensure that shareholders benefit from both the stable growth of Fancamp's investment portfolio and the exploration potential of Goldera [5][11]

Core Insights - Harfang Exploration Inc. has announced significant discoveries at its Menarik East project, confirming the presence of a large critical and strategic minerals domain associated with the Menarik Igneous Complex [1][3][7] Summer Program Overview - The summer exploration campaign aimed to verify historical results of copper and nickel mineralization and evaluate new high-priority critical and strategic mineral targets [4] - The program confirmed the presence of Cu, Ni, PGE, and Cr mineralization, outlining new copper and nickel showings [5][11] Geological Comparisons - Menarik East shows geological similarities to major discoveries in Ontario's Ring of Fire, particularly in its chromite-PGE-rich layers and nickel-copper areas [3][11] - The project has two defined polymetallic domains: the West Domain with strong copper-nickel potential and the Central Domain characterized by enriched nickel-PGE-chromium [6][11] Assay Results - Notable assay results from the West Domain include 8.57% CuEq, 3.39% CuEq, and 1.53% CuEq, while the Central Domain shows results of 0.91% NiEq and 0.74% NiEq [6][11] - Historical resources in the project area include 1.0 million tonnes grading 0.38% Ni and 0.15% Cu, and 6.19 million tonnes grading 7.69% Cr₂O₃ [7][17] Project Characteristics - The Menarik East project covers approximately 4,200 hectares and is characterized by a large ultramafic system known for critical and strategic minerals [16][17] - The project is accessible via the Billy Diamond Highway and the Trans-Taiga Road [16] Sampling and Quality Control - Rock samples were analyzed for various elements, with strict quality control protocols in place, including the use of certified reference materials [18]

Core Insights - Fancamp Exploration Ltd. has appointed Mr. Jasper Bertisen to its Board of Directors, effective immediately, to support its strategic reorganization [1][4] Company Overview - Fancamp is a Canadian mineral exploration company focused on medium-term growth and monetization opportunities, with interests in high-potential mineral projects and a royalty portfolio [5] - The company holds significant interests in various minerals, including copper, gold, zinc, titanium, chromium, and rare-earth metals, with a notable asset being the Magpie property, one of the largest undeveloped hard rock titanium deposits globally [5] Leadership and Expertise - Mr. Jasper Bertisen brings over 20 years of experience in global mining investment and governance, having managed an $800 million portfolio and contributed to over $3.5 billion in capital raised during his tenure at Resource Capital Funds [2] - His expertise in evaluating mining projects from both technical and financial perspectives is expected to enhance Fancamp's strategic direction [2][4] Strategic Reorganization - Fancamp plans to separate its financial assets from its exploration assets, creating two distinct entities, with the financial entity focusing on investments, royalties, and other financial instruments [3] - This reorganization aims to streamline the portfolio and emphasize growth through strategic acquisitions [3]

Summary of 10X Genomics Conference Call Company Overview - **Company**: 10X Genomics (NasdaqGS:TXG) - **Industry**: Biotechnology, specifically focusing on single-cell analysis and spatial omics Key Points and Arguments Company Position and Strategy - 10X Genomics is recognized as a market leader in single-cell analysis and spatial omics, with a strong emphasis on innovation and continuous improvement [1][2] - The company underwent significant restructuring in the past year, which has positioned it well to navigate a challenging macro environment [6][7] - The executive team changes and commercial restructuring have allowed for better responsiveness to market conditions [15][16] Market Environment - The current market environment is described as "choppy and uncertain," but there are signs of improvement in customer sentiment compared to earlier in the year [12][13] - Funding uncertainties, particularly related to NIH funding and multi-year funding, continue to pose challenges [11][12] Commercial Performance - The new commercial organization is performing well, with strong metrics in funnel management and opportunity generation despite macroeconomic challenges [18][19] - The company has seen growth in Chromium reaction and spatial consumables, indicating positive underlying business fundamentals [8][9] Pricing Strategy - 10X Genomics is actively working on pricing strategies to drive volume, particularly in single-cell consumables, by introducing lower price points and new product configurations [22][23] - The company anticipates that pricing pressures will normalize over the next few quarters, allowing for a better balance between pricing and volume [25][26] Competitive Landscape - The competitive landscape remains intense, but 10X Genomics believes it has maintained an advantage in product performance, quality, and customer satisfaction [44][45] - The company is sequencer agnostic, which enhances its competitive position as new sequencers enter the market [47][49] Future Opportunities - There is a growing interest in large-scale single-cell programs, particularly with the integration of AI in biological modeling, which could drive demand for 10X Genomics' products [30][32] - The company is open to partnerships with tech firms to leverage AI and enhance data analysis capabilities [37][38] Spatial Omics - Spatial technology is still in an earlier stage of development compared to single-cell technology, but it is expected to become increasingly important as the company improves its offerings [39][40] Financial Guidance - The company is cautious about providing financial guidance due to ongoing uncertainties in the market, but it remains optimistic about the underlying drivers of the business [54][59] Additional Important Insights - The company has made significant strides in product launches, including the recent introduction of the Flex assay, which is expected to enhance market performance [50][51] - There is a belief that substantial public investment in large-scale biological modeling could yield significant benefits for the industry [35][36]